A retrospective study assessing the efficacy and safety of Secukinumab in patients with moderate to severe psoriasis in routine clinical practice
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Secukinumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2017 New trial record